Etgar Levy‐Nissenbaum

5.6k total citations · 2 hit papers
27 papers, 4.3k citations indexed

About

Etgar Levy‐Nissenbaum is a scholar working on Molecular Biology, Biomaterials and Pharmaceutical Science. According to data from OpenAlex, Etgar Levy‐Nissenbaum has authored 27 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 6 papers in Biomaterials and 5 papers in Pharmaceutical Science. Recurrent topics in Etgar Levy‐Nissenbaum's work include RNA Interference and Gene Delivery (7 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Nanoparticle-Based Drug Delivery (6 papers). Etgar Levy‐Nissenbaum is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Nanoparticle-Based Drug Delivery (6 papers). Etgar Levy‐Nissenbaum collaborates with scholars based in Israel, United States and United Kingdom. Etgar Levy‐Nissenbaum's co-authors include Omid C. Farokhzad, Róbert Langer, Frank Gu, Liangfang Zhang, Benjamin A. Teply, Frank Alexis, Sangyong Jon, Vaishali Bagalkot, Philip W. Kantoff and Jianjun Cheng and has published in prestigious journals such as Circulation, Nature Genetics and Nano Letters.

In The Last Decade

Etgar Levy‐Nissenbaum

27 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug delivery

2006 1.0k citations Jianjun Cheng, Benjamin A. Teply et al. Biomaterials profile →
Quantum Dot−Aptamer Conjugates for Synchronous Cancer Imaging, Therapy, and Sensing of Drug Delivery Based on Bi-Fluorescence Resonance Energy Transfer

2007 751 citations Vaishali Bagalkot, Liangfang Zhang et al. Nano Letters profile →

Peers

Etgar Levy‐Nissenbaum

BIOMA

CCM

Tatyana Levchenko United States

María J. Blanco‐Prieto Spain

Hongyan Zhu China

Tianjiao Ji China

Rivka Cohen Israel

Michael Chorny United States

Sun Hwa Kim South Korea

Silvia Muro United States

Yoshiharu Minamitake Japan

Olivia M. Merkel Germany

Tatyana Levchenko United States

Etgar Levy‐Nissenbaum

2.7k ×1.2

1.3k ×0.9

BIOMA

864 ×0.7

155 ×0.2

CCM

432 ×0.7

Citations per year, relative to Etgar Levy‐Nissenbaum Etgar Levy‐Nissenbaum (= 1×) peers Tatyana Levchenko

Countries citing papers authored by Etgar Levy‐Nissenbaum

Since Specialization

Citations

This map shows the geographic impact of Etgar Levy‐Nissenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Etgar Levy‐Nissenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Etgar Levy‐Nissenbaum more than expected).

Fields of papers citing papers by Etgar Levy‐Nissenbaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Etgar Levy‐Nissenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Etgar Levy‐Nissenbaum. The network helps show where Etgar Levy‐Nissenbaum may publish in the future.

Co-authorship network of co-authors of Etgar Levy‐Nissenbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Etgar Levy‐Nissenbaum. A scholar is included among the top collaborators of Etgar Levy‐Nissenbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Etgar Levy‐Nissenbaum. Etgar Levy‐Nissenbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Courtenay, Aaron J., Emma McAlister, Maelíosa McCrudden, et al.. (2020). Hydrogel-forming microneedle arrays as a therapeutic option for transdermal esketamine delivery. Journal of Controlled Release. 322. 177–186. 125 indexed citations

Dotan, Iris, Etgar Levy‐Nissenbaum, Yehuda Chowers, et al.. (2016). Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II Trial. Digestive Diseases and Sciences. 61(11). 3246–3254. 10 indexed citations

Pridgen, Eric M., Frank Alexis, Timothy Kuo, et al.. (2013). Transepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery. DSpace@MIT (Massachusetts Institute of Technology). 1 indexed citations

Levy‐Nissenbaum, Etgar, Wahid Khan, Rajendra P. Pawar, et al.. (2012). Pharmacokinetic and efficacy study of cisplatin and paclitaxel formulated in a new injectable poly(sebacic-co-ricinoleic acid) polymer. European Journal of Pharmaceutics and Biopharmaceutics. 82(1). 85–93. 12 indexed citations

Xiao, Zeyu, Etgar Levy‐Nissenbaum, Frank Alexis, et al.. (2012). Engineering of Targeted Nanoparticles for Cancer Therapy Using Internalizing Aptamers Isolated by Cell-Uptake Selection. ACS Nano. 6(1). 696–704. 129 indexed citations

Gaidukov, Leonid, et al.. (2009). In vivo administration of BL-3050: highly stable engineered PON1-HDL complexes. PubMed. 9(1). 18–18. 35 indexed citations

Alexis, Frank, Pamela A. Basto, Etgar Levy‐Nissenbaum, et al.. (2008). HER‐2‐Targeted Nanoparticle–Affibody Bioconjugates for Cancer Therapy. ChemMedChem. 3(12). 1839–1843. 117 indexed citations

Levy‐Nissenbaum, Etgar, Aleksandar F. Radovic‐Moreno, Andrew Z. Wang, Róbert Langer, & Omid C. Farokhzad. (2008). Nanotechnology and aptamers: applications in drug delivery. Trends in biotechnology. 26(8). 442–449. 210 indexed citations

Zhang, Liangfang, Vaishali Bagalkot, Etgar Levy‐Nissenbaum, et al.. (2007). Quantum dot-aptamer conjugates for synchronous cancer imaging and therapy based on bi-fluorescence resonance energy transfer. Clinical Cancer Research. 13. 2 indexed citations

10.

Alexis, Frank, et al.. (2007). Targeted Aptamer-Nanoparticles to Diminish Drug Resistance of Cancer Cells in vitro Study. TechConnect Briefs. 2(2007). 366–369. 4 indexed citations

11.

Gu, Frank, Rohit Karnik, Andrew Z. Wang, et al.. (2007). Targeted nanoparticles for cancer therapy. Nano Today. 2(3). 14–21. 391 indexed citations

12.

Bagalkot, Vaishali, Liangfang Zhang, Etgar Levy‐Nissenbaum, et al.. (2007). Quantum Dot−Aptamer Conjugates for Synchronous Cancer Imaging, Therapy, and Sensing of Drug Delivery Based on Bi-Fluorescence Resonance Energy Transfer. Nano Letters. 7(10). 3065–3070. 751 indexed citations breakdown →

13.

Cheng, Jianjun, Benjamin A. Teply, Joseph J.�Y. Sung, et al.. (2006). Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug delivery. Biomaterials. 28(5). 869–876. 1020 indexed citations breakdown →

14.

Levy‐Nissenbaum, Etgar, Michal Bar‐Natan, Moshe Frydman, & Elon Pras. (2006). Confirmation of the association between male pattern baldness and the androgen receptor gene.. PubMed. 15(5). 339–40. 44 indexed citations

15.

Levy‐Nissenbaum, Etgar, et al.. (2003). Clinical manifestations in Israeli cystinuria patients and molecular assessment of carrier rates in Libyan Jewish controls.. PubMed. 5(6). 439–42. 7 indexed citations

16.

Levy‐Nissenbaum, Etgar, Regina C. Betz, Moshe Frydman, et al.. (2003). Hypotrichosis simplex of the scalp is associated with nonsense mutations in CDSN encoding corneodesmosin. Nature Genetics. 34(2). 151–153. 108 indexed citations

17.

Ben‐Zeev, Bruria, Etgar Levy‐Nissenbaum, Hadas Lahat, et al.. (2002). Megalencephalic leukoencephalopathy with subcortical cysts; a founder effect in Israeli patients and a higher than expected carrier rate among Libyan Jews. Human Genetics. 111(2). 214–218. 27 indexed citations

18.

Pras, Eran, Etgar Levy‐Nissenbaum, Hadas Lahat, et al.. (2002). A Missense Mutation in the LIM2 Gene Is Associated with Autosomal Recessive Presenile Cataract in an Inbred Iraqi Jewish Family. The American Journal of Human Genetics. 70(5). 1363–1367. 92 indexed citations

19.

Levy‐Nissenbaum, Etgar, Michael Eldar, Qing Wang, et al.. (2001). Genetic Analysis of Brugada Syndrome in Israel: Two Novel Mutations and Possible Genetic Heterogeneity. Genetic Testing. 5(4). 331–334. 13 indexed citations

20.

Lahat, Hadas, Elon Pras, Nili Avidan, et al.. (2001). A Missense Mutation in a Highly Conserved Region of CASQ2 Is Associated with Autosomal Recessive Catecholamine-Induced Polymorphic Ventricular Tachycardia in Bedouin Families from Israel. The American Journal of Human Genetics. 69(6). 1378–1384. 461 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact